Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
BJU International|October 10, 2007
Can non-malignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at re-screening after 4 years?Tineke Wolters, Monique J Roobol, Fritz H Schröder, et al.
Cancer|January 13, 2010
Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes?Roderick C N van den Bergh, Ewout W Steyerberg, Ali Khatami, et al.
European Urology|August 18, 2009
Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohortAndrew J Vickers, Tineke Wolters, Caroline J Savage, et al.
European Urology|August 12, 2009
Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancerTineke Wolters, Monique J Roobol, Pim J van Leeuwen, et al.
The Journal of Urology|November 16, 2010
A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trialTineke Wolters, Monique J Roobol, Pim J van Leeuwen, et al.
Urology|March 4, 2014
Prostate cancer antigen 3: diagnostic outcomes in men presenting with urinary prostate cancer antigen 3 scores ≥100Fritz H Schröder, Lionne D F Venderbos, Roderick C N van den Bergh, et al.
International Journal of Cancer|September 10, 2009
The effect of study arm on prostate cancer treatment in the large screening trial ERSPCTineke Wolters, Monique J Roobol, Ewout W Steyerberg, et al.
The Prostate|May 4, 2011
Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomyTineke Wolters, Rodolfo Montironi, Roberta Mazzucchelli, et al.
European Urology|March 28, 2022
A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging-directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naïve MenIvo M Wagensveld, Daniel F Osses, Pieter M Groenendijk, et al.
European Urology Oncology|November 29, 2025
Extending Current Guideline-recommended Prostate-specific Antigen Density Thresholds for Improving Benefit/Harm Balance in Risk-based Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis, from the Community-based Multicentre MR-PROPER StudyAnne M A Prinsen, Ivo M Wagensveld, Daniel F Osses, et al.
Pageof 3